Liothyronine vs Levothyroxine
The table compares the compounds’ key data from their entry pages. Open each compound’s full entry for details. Educational content, not medical advice.
Liothyronine (T3, Cytomel) | Levothyroxine (T4, Synthroid) | |
|---|---|---|
| What it is | Prescription thyroid hormone (T3) that bodybuilders also use for fat burning; not indicated for weight loss, can cause heart problems. | Prescription thyroid hormone medicine for an underactive thyroid; athletes also take it to lose fat, which is not justified without a diagnosis. |
| Mechanism of actionMechanism of actionThe molecular pathway by which a compound acts in the body (e.g. which receptor or enzyme it binds). | Nuclear TR-α + TR-β receptor agonist, gene-transcription activation, +10-30% REE | Thyroid prohormone, peripheral D1/D2 conversion to T3, indirect nuclear TR-α/β agonist |
| Dosing | Clinical 25-50 μg/day; off-label cutting-cycle 25-75 μg/day, titration 12.5 μg/step | Clinical 1.6 μg/kg/day (100-150 μg/day); off-label cutting 200-300 μg/day (NOT recommended) |
| Half-lifeHalf-lifeThe time for the compound’s plasma concentration to fall by half; indicates how fast it clears and how often it is dosed. | ~24 hours (steady-state within 7 days) | ~7 days (steady-state ~6 weeks) |
| OnsetOnsetThe time from dosing until a measurable effect appears. | Metabolic-rate increase 24-48 hours, fat-loss effect 1-2 weeks | Metabolic-rate increase 1-2 weeks; steady-state 6 weeks |
| Legal statusLegal / WADA statusThe compound’s regulatory status (e.g. prescription) and its place on the WADA prohibited-in-sport list. | FDA + EMA Rx (hypothyroidism), registered in HU + PL. WADA: S4.5 in-competition banned for non-Rx athletes. | FDA + EMA Rx (hypothyroidism), registered in HU + PL. WADA: allowed with documented hypothyroidism diagnosis, off-label cutting is NOT legitimate. |
| Full entry | Open → | Open → |
Liothyronine or levothyroxine: what is the difference?
Both are prescription thyroid hormones approved for an underactive thyroid: liothyronine is the synthetic form of T3, the active hormone, and levothyroxine of T4, from which the active T3 is made in the tissues. So liothyronine starts working faster and its effect also fades faster, while levothyroxine acts more slowly and provides a steady supply; according to their entries the half-life is about 24 hours and about 7 days respectively. Levothyroxine is the standard treatment for an underactive thyroid. Both dampen, through feedback, the production of TSH, the pituitary hormone that stimulates the thyroid. Athletes also use both to lose fat; according to their entries this is off-label use, or not justified without a diagnosis.
